BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7549222)

  • 1. Effect of zatebradine, a novel 'sinus node inhibitor', on pulmonary function compared to placebo.
    Maesen FP; Smeets JJ; van Noord JA; Nehmiz G; Wald FD; Cornelissen PJ
    Pulm Pharmacol; 1994 Dec; 7(6):349-55. PubMed ID: 7549222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
    Twentyman OP; Finnerty JP; Holgate ST
    Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single-dose zileuton on bronchial hyperresponsiveness in asthmatic patients treated with inhaled corticosteroids.
    Dekhuijzen PN; Bootsma GP; Wielders PL; van den Berg LR; Festen J; van Herwaarden CL
    Eur Respir J; 1997 Dec; 10(12):2749-53. PubMed ID: 9493655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.
    van Schayck CP; Cloosterman SG; Bijl-Hofland ID; van den Hoogen H; Folgering HT; van Weel C
    Respir Med; 2002 Mar; 96(3):155-62. PubMed ID: 11908511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone.
    Groeben H; Silvanus MT; Beste M; Peters J
    Anesthesiology; 1998 Oct; 89(4):862-8. PubMed ID: 9778003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A; Lipworth BJ
    Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
    Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
    J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
    Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
    Gongora HC; Wisniewski AF; Tattersfield AE
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H; Willenbrock U; Jörres R
    Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway calibre as a confounder in interpreting bronchial responsiveness in asthma.
    Dirksen A; Madsen F; Engel T; Frølund L; Heinig JH; Mosbech H
    Thorax; 1992 Sep; 47(9):702-6. PubMed ID: 1359666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of preventive effect of inhaled salbutamol on early airway response to allergen in asthmatic subjects.
    Paggiaro PL; Dente FL; Vagaggini B; Bancalari L; Carrara M; Di Franco A; Giannini D; Bacci E; Testi R; Giuntini C
    Respir Med; 1993 Feb; 87(2):121-6. PubMed ID: 8497681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
    Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
    Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma.
    Boskabady MH; Saadatinejad M
    J Asthma; 2003 Dec; 40(8):917-25. PubMed ID: 14736092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchial responsiveness to inhaled histamine in both adults with intrinsic and extrinsic asthma: the importance of prechallenge forced expiratory volume in 1 second.
    Ulrik CS
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):120-6. PubMed ID: 7678613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pretreatment with inhaled methoxamine on bronchial responses to histamine in asthmatic subjects.
    Phan-Puibaraud TT; Regnard J; Monchi M; Dall'Ava-Santucci J; Lockhart A; Dinh-Xuan AT
    Eur Respir J; 1995 Jan; 8(1):40-6. PubMed ID: 7744192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular inhaled salbutamol and airway responsiveness to allergen.
    Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
    Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
    Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
    Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.